Journal: eLife
Article Title: Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity
doi: 10.7554/elife.73282
Figure Lengend Snippet: Figure 4. SHP-1 phosphorylation is mediated through PKC-θ. (A) Silencing efficiency of PKC-θ. YTS-2DL1 cells treated with either nonspecific (control) (NS) or PKC-θ siRNA, lysed, separated on SDS-PAGE, and immunoblotted with anti- PKC-θ antibody. PKC-θ levels were measured by densitometric analysis, relative to the GAPDH loading control using ImageJ. Samples were normalized to the sample treated with NS siRNA (p=0.001, quantification on the bottom showing average of three independent experiments). (B) YTS-2DL1 treated with either NS or PKC-θ siRNA were incubated with 721- HLA target cells at 37°C for 5 min, and cells were subsequently lysed. Lysates were separated on SDS-PAGE, transferred to a nitrocellulose membrane, and immunoblotted with anti-pSHP-1 S591 antibody. SHP-1 S591 phosphorylation levels were measured by densitometric analysis, relative to the GAPDH loading control using ImageJ. Samples were normalized to the YTS-2DL1 sample treated with NS siRNA and incubated with 721-Cw7 targets (p=0.0072, quantification on the bottom of independent experiments, n = 3). (C) Silencing efficiency of PKC-θ. pNK-2DL1 cells were transfected with 250 pmol of PKC-θ siRNA. After 48 hr, prior to incubation with target cells, pNK-2DL1 were counted and lysed. Lysates were separated on SDS-PAGE and immunoblotted with anti-PKC-θ antibody. PKC-θ expression levels were measured by densitometric analysis using ImageJ and expressed relative to the GAPDH loading control. Samples were normalized according to the pNK-NS siRNA sample. Bar graph on the bottom shows the average of three independent experiments. (D) pNK-2DL1 cells were incubated with 721-HLA-negative cells at 37°C for 5 min, and cells were subsequently lysed. Lysates were separated on SDS-PAGE and transferred to a nitrocellulose membrane that was immunoblotted with anti-pSHP-1 S591 antibody. SHP-1 S591 phosphorylation levels were measured by densitometric analysis, relative to the GAPDH loading control using ImageJ. Samples were normalized to the pNK-2DL1 sample treated with NS siRNA and incubated with 721 targets (p=0.0113, quantification on the bottom showing the average of three independent experiments). Data are shown as mean ± SEM. One-sample t-tests (A–D) were used to calculate p-values.
Article Snippet: DOI: https://doi.org/10.7554/eLife.73282 19 of 30 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Antibody Anti- human VAV1 (D7) (mouse monoclonal) Santa Cruz SC- 8039 IB: 1:500 (14 μL) Antibody Anti- human SHP- 1 (SH- PTP- 1) (C- 19) (rabbit polyclonal) Santa Cruz SC- 287 IB: 1:1000 (7 μL) Antibody Anti- human GAPDH (0411) (mouse monoclonal) Santa Cruz SC- 47724 IB: 1:1000 (7 μL) Antibody Anti- human pSHP- 1 (S591) (rabbit polyclonal) ECM Biosciences Sp- 1531 IB: 1:1000 (7 μL) IF: 1:500 (0.6 μL) Antibody Anti- human pPLCγ (Y783) (rabbit polyclonal) Cell Signaling CST- 2821S IB: 1:1000 (7 μL) IF: 1:500 (0.6 μL) Antibody Anti- human pVAV1 (Y160) (rabbit polyclonal) Bio Source Bs- 44482 IB: 1:1000 (7 μL) IF: 1:500 (0.6 μL) Antibody Anti- human- PKC-θ (1C2) (mouse monoclonal) Santa Cruz SC- 81534 IB: 1:500 (14 μL) IF: 1:250 (1.2 μL) Antibody Goat anti- mouse Jackson Laboratory #115- 035- 003 1:10,000 (1 μL) Antibody Goat anti- rabbit Santa Cruz Sc- 2004 1:10,000 (1 μL) Antibody Anti- human KIR2DL1/ S1- PE conjugated (mouse monoclonal) Miltenyi Biotec 130- 099- 209 1:10 (10 μL) Antibody Anti- human CD107a (LAMP- 1) (mouse monoclonal) BioLegend #328602 1:20 (2.5 μL) Antibody Alexa Fluor- conjugated 488 (goat polyclonal) anti- rabbit IgG (H+L) Highly CrossAdsorbed Secondary Antibody Invitrogen A11034 IF: 1:2000 (1 μL) Antibody Alexa Fluor- conjugated 488 goat polyclonal anti- mouse IgG (H+L) Jackson Laboratory 115- 545- 146 IF: 1:2000 (1 μL) Recombinant DNA reagent YFP- SHP- 1- CFP (plasmid) Matalon et al., 2018 Recombinant DNA reagent CRISPR CAS9 SHP- 1 S591D Ben- Shmuel et al., 2021 Backbone pSpCas9 (BB)–2A- GFP vector Addgene plasmid #48138 Sequence- based reagent siRNA: target PRKCQ gene Sigma- Aldrich 5′ CUCUUCACCUGGGCGCCAA 3′ 5′ UUGGCGCCCAGGUGAAGAG 3′ Sequence- based reagent siRNA: nonspecific target Sigma- Aldrich 5′ UAGCGACUAAACACAUCAA 3′, 5′UAAGGCUAUGAAGAGAUAC3′, 5′AUGUAUUGGCCUGUAUUAG3′, 5′ AUGAACGUGAAUUGCUCAA 3′, and 5′ UGGUUUACAUGUCGACUAA3′ Chemical compound, drug Fluo- 3- AM Biotium 50016 1 μg per sample Chemical compound, drug p- Nitophenyl phosphate (pNPP) NEB- P0757S Chemical compound, drug [35S]Met PerkinElmer NEG009L005MC Chemical compound, drug Monensin BioLegend #420701 Chemical reagent Mirus Ingenio Solution MIR50111 Chemical compound, reagent Enhanced chemiluminescence PerkinElmer, Life Gene NEL105001EA, AC2103 Continued on next page Ben- Shmuel, Sabag, et al. eLife 2022;11:e73282.
Techniques: Phospho-proteomics, Control, SDS Page, Incubation, Membrane, Transfection, Expressing